Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions
SEC Form 4 Filing
Director Tariq Musa reports the vesting and conversion of restricted stock units into common stock.
Summary
- On March 15, 2024, Tariq Musa, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- Specifically, 2,998 restricted stock units vested and were converted into 2,998 shares of common stock.
- The transaction was executed at a price of $0 per share.
- Following the transaction, Musa directly owns 8,994 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure related to insider transactions and is a standard part of regulatory compliance for publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the conversion of existing equity compensation.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date the restricted stock units were granted. |
| 03/15/2023 | First vesting date of the restricted stock units (25%). |
| 03/15/2024 | Date of the reported transaction where restricted stock units vested and converted to common stock. |
| 03/18/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.